Phase
Condition
Cancer
Lung Disease
Lung Cancer
Treatment
Circulating Tumor DNA (ctDNA) Assay
Clinical Study ID
Ages 40-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria (Aims 1, 2, and 3) for Group 1 (50 through 80 years of age):
Non-tobacco using (currently)
Self-identify as East Asian (including Southeast Asian) or Hispanic/Latinx.
East Asian includes those who self-identify as Chinese, Japanese, Korean, Taiwanese, Malaysian
Southeast Asian includes those who self-identify as Cambodian, Thai, Vietnamese, Filipino
Latinx includes those who self-identify as a person of Central or South American and the Caribbean including, Cuban, Puerto Rican, and Dominican culture or origin, excluding individuals originating from Spain
Aims 1 and 2: Able to complete and understand the study's informed consent in English, Mandarin, Cantonese, Japanese, Korean, Vietnamese, Spanish, Portuguese, or Cape Verdean
Aim 3: Able to complete and understand the study's informed consent and participate in a focus group in English, Mandarin, Vietnamese, or Spanish.
Inclusion Criteria (Aims 1, 2, and 3) for Group 2 (40 through 49 years of age):
Non-tobacco using (currently)
Self-identify as East Asian (including Southeast Asian) or Latinx, if any of the following criteria are met:
Family history of EGFR positive LC L858R or exon 19
Personal history of remote cancer that is not LC or other thoracic malignancies, including thymoma, thymic carcinoma, or sarcoma, as long as it was resolved over 5 years ago
History of TB, asthma requiring daily inhaled corticosteroids or chronic bronchitis
Symptoms of lung cancer for the past month, including hemoptysis, unexplained weight loss, voice hoarseness, cough or worsening cough, dyspnea or worsening dyspnea
Excluding individuals who concurrently present with fever, covid/influenza/RSV/adenovirus infection, runny nose, sore throat, productive cough with green or yellow sputum
Aims 1 and 2: Able to complete and understand the study's informed consent in English, Mandarin, Cantonese, Japanese, Korean, Vietnamese, Spanish, Portuguese, or Cape Verdean
Aim 3: Able to complete and understand the study's informed consent and participate in a focus group in English, Mandarin, Vietnamese, or Spanish.
Exclusion Criteria (Aims 1, 2, and 3) for Groups 1 and 2:
Having had a chest CT scan in the last 3 years or having an anticipated chest CT scan during the enrollment period.
Having a current cancer or history of cancer within the last 5 years, excluding localized non-melanoma skin cancer and breast ductal carcinoma in situ.
More than 400 lifetime cigarettes (i.e., 20 packs) of smoking or tobacco use
Adults unable to provide informed consent
Individuals <40 years of age
Prisoners
Pregnant women
Personal diagnosis of lung cancer
Not able to be compliant with study requirements
Study Design
Study Description
Connect with a study center
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United StatesSite Not Available
Boston Medical Center
Boston, Massachusetts 02118
United StatesSite Not Available
Dana-Farber Cancer Institute
Boston, Massachusetts 02215
United StatesActive - Recruiting
Massachusetts General Hospital
Boston, Massachusetts 02215
United StatesSite Not Available
Dana-Farber Cancer Institute at Steward St. Elizabeth's
Brighton, Massachusetts 02135
United StatesSite Not Available
Dana-Farber Cancer Instiute Merrimack Valley
Methuen, Massachusetts 01844
United StatesSite Not Available
Dana-Farber Cancer Institute South Shore
South Weymouth, Massachusetts 02190
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.